BMI1 and B-cell chronic lymphocytic leukemia: Our tumor driver screening also supports this hypothesis since constitutive activity of well-known factors of CLL disease progression, such as PI3K/AKT, MAPK, or NOTCH1 activation, combined with BMI1 activity, led to a proliferative attractor.